Technology Platforms for Monoclonal Antibody Development and Production

Presented By:
Amy Sheng, Ph.D.

Speaker Biography:
Dr. Amy Sheng is a technical account manager in Sino Biological. Dr. Sheng joined Sino Biological in 2021 supporting CRO services and project management in Eastern US region. Prior to joining Sino Biological, she worked in Caprico Biotechnologies as production manager in charge of antibody development and production for flow cytometry. She has a Ph.D. in Molecular and Cell Biology from Georgia Institute of Technology, and is ASCP-certified molecular biologist and ASQ-certified CSSGB.

Webinar:
Technology Platforms for Monoclonal Antibody Development and Production

Webinar Abstract:
Monoclonal antibody (mAb) is generated from a single clone of an antibody-producing cell and recognizes one specific epitope. It has been known for its advantages of high specificity, sensitivity, batch-to-batch consistency, and scalability. Moreover, recombinant antibody engineering has brought a revolution to mAb production and tremendously expanded the applications to in vitro diagnostics and clinical uses for cancers, immune-deficiency diseases, viral infections, etc.

The webinar will focus on the development of mAb through hybridoma, phage display, and single B cell sorting techniques, as well as a discussion regarding mAb applications and R&D case studies.

Earn PACE Credits:
1. Make sure you're a registered member of LabRoots (https://www.labroots.com/ms/webinar/t...)  
2. Watch the webinar on the LabRoots Website (https://www.labroots.com/ms/webinar/t...)  
3. Click Here to get your PACE credits (Expiration date – MAY 17, 2024): (https://www.labroots.com/credit/pace-...)

LabRoots on Social:
Facebook: Facebook: LabRootsInc
Twitter: Twitter: LabRoots
LinkedIn: LinkedIn: labroots
Instagram: Instagram: labrootsinc
Pinterest: Pinterest: labroots
SnapChat: labroots_inc